WAVE life science limited is a preclinical pharmaceutical company. It is using the proprietary chemistry platform for designing, developing and commercializing the stereo pure nucleic acid therapeutics candidates. The company has very recently announced that they are planning to enter into IPO soon. After the announcement, the company has involved in further steps to get into IPO. But the price for the shares was not informed at any of their official announcement. Today the company has made an official announcement that makes it clear about the price of each share in this IPO.
Per share of WAVE will cost $16.00
In the official announcement that the company has made today, it was clearly mentioned that each share of WAVE in this IPO will be sold at a price of $16.00. The company has planned to sell about 6,375,000 shares in this IPO. Also the company has granted the under writers with an extra 30 days time. The extra time for the under writers will allow them to buy an extra share of 956,250. The sources from the company have told that the share price what the company has announced today will not be including the processing charges.
According to the data available with the reporters, the IPO of the WAVE will be starting in the NASDAQ Global Market by this November 11, 2015. Also the IPO symbol was announced. The symbol for the WAVE in this IPO will be “WVE’. The marketers have told that they are feeling good to see the WAVE life science limited into IPO. They have also told that they are interested in buying the shares of WAVE as the chemical industry will have a great future and they expect that the shares of WAVE will bring them good returns in the future.
IPO will follow the prospectus strictly
The company has made it very clear that the IPO of the company will be strictly following the guidelines that have been mentioned in the preliminary prospectus. Hence the marketers are advised to go through the preliminary prospectus before deciding on their investment in the WAVE shares. The company has told that the preliminary prospectus will be available with the Securities and Exchange Commission website. Also the prospectus can be sent to the investors through e-mail if the investors are making a request to the company. Also the final prospectus copies are available with the book runners.
Jefferies and Leerink Partners are going to act as the managers for joint book running. The SunTrust Robinson Humphrey and the JMP Securities are going to act as the co managers for this offering. The registration statements that are related to this IPO are filed with the SEC. All these statements can be viewed in the SEC website. These statements were declared effective by this November 10, 2015. Any press release of WAVE dated before November 10, containing any offer or announcement regarding the IPO will be considered as unlawful. Marketers now have started going through the prospectus.
Per share of WAVE will cost $16.00
In the official announcement that the company has made today, it was clearly mentioned that each share of WAVE in this IPO will be sold at a price of $16.00. The company has planned to sell about 6,375,000 shares in this IPO. Also the company has granted the under writers with an extra 30 days time. The extra time for the under writers will allow them to buy an extra share of 956,250. The sources from the company have told that the share price what the company has announced today will not be including the processing charges.
According to the data available with the reporters, the IPO of the WAVE will be starting in the NASDAQ Global Market by this November 11, 2015. Also the IPO symbol was announced. The symbol for the WAVE in this IPO will be “WVE’. The marketers have told that they are feeling good to see the WAVE life science limited into IPO. They have also told that they are interested in buying the shares of WAVE as the chemical industry will have a great future and they expect that the shares of WAVE will bring them good returns in the future.
IPO will follow the prospectus strictly
The company has made it very clear that the IPO of the company will be strictly following the guidelines that have been mentioned in the preliminary prospectus. Hence the marketers are advised to go through the preliminary prospectus before deciding on their investment in the WAVE shares. The company has told that the preliminary prospectus will be available with the Securities and Exchange Commission website. Also the prospectus can be sent to the investors through e-mail if the investors are making a request to the company. Also the final prospectus copies are available with the book runners.
Jefferies and Leerink Partners are going to act as the managers for joint book running. The SunTrust Robinson Humphrey and the JMP Securities are going to act as the co managers for this offering. The registration statements that are related to this IPO are filed with the SEC. All these statements can be viewed in the SEC website. These statements were declared effective by this November 10, 2015. Any press release of WAVE dated before November 10, containing any offer or announcement regarding the IPO will be considered as unlawful. Marketers now have started going through the prospectus.